Your browser doesn't support javascript.
loading
Predicting Penicillin Allergy: A United States Multicenter Retrospective Study.
Gonzalez-Estrada, Alexei; Park, Miguel A; Accarino, John J O; Banerji, Aleena; Carrillo-Martin, Ismael; D'Netto, Michael E; Garzon-Siatoya, W Tatiana; Hardway, Heather D; Joundi, Hajara; Kinate, Susan; Plager, Jessica H; Rank, Matthew A; Rukasin, Christine R F; Samarakoon, Upeka; Volcheck, Gerald W; Weston, Alexander D; Wolfson, Anna R; Blumenthal, Kimberly G.
Afiliación
  • Gonzalez-Estrada A; Division of Pulmonary, Allergy, and Sleep Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Fla.
  • Park MA; Division of Allergic Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minn.
  • Accarino JJO; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
  • Banerji A; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
  • Carrillo-Martin I; Division of Pulmonary, Allergy, and Sleep Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Fla.
  • D'Netto ME; Division of Allergic Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minn.
  • Garzon-Siatoya WT; Division of Pulmonary, Allergy, and Sleep Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Fla.
  • Hardway HD; Digital Innovation Lab, Department of Health Sciences Research, Mayo Clinic, Jacksonville, Fla.
  • Joundi H; Division of Pulmonary, Allergy, and Sleep Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Fla.
  • Kinate S; Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic, Scottsdale, Ariz.
  • Plager JH; Department of Medicine, Massachusetts General Hospital, Boston, Mass.
  • Rank MA; Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic, Scottsdale, Ariz; Section of Allergy, Immunology, Division of Pulmonary, Phoenix Children's Hospital, Phoenix, Ariz.
  • Rukasin CRF; Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic, Scottsdale, Ariz; Section of Allergy, Immunology, Division of Pulmonary, Phoenix Children's Hospital, Phoenix, Ariz.
  • Samarakoon U; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
  • Volcheck GW; Division of Allergic Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minn.
  • Weston AD; Digital Innovation Lab, Department of Health Sciences Research, Mayo Clinic, Jacksonville, Fla.
  • Wolfson AR; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
  • Blumenthal KG; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass. Electronic address: kblumenthal@mgh.harvard.edu.
J Allergy Clin Immunol Pract ; 12(5): 1181-1191.e10, 2024 May.
Article en En | MEDLINE | ID: mdl-38242531
ABSTRACT

BACKGROUND:

Using the reaction history in logistic regression and machine learning (ML) models to predict penicillin allergy has been reported based on non-US data.

OBJECTIVE:

We developed ML positive penicillin allergy testing prediction models from multisite US data.

METHODS:

Retrospective data from 4 US-based hospitals were grouped into 4 datasets enriched training (13 case-control matched cohort), enriched testing, nonenriched internal testing, and nonenriched external testing. ML algorithms were used for model development. We determined area under the curve (AUC) and applied the Shapley Additive exPlanations (SHAP) framework to interpret risk drivers.

RESULTS:

Of 4777 patients (mean age 60 [standard deviation 17] years; 68% women, 91% White, and 86% non-Hispanic) evaluated for penicillin allergy labels, 513 (11%) had positive penicillin allergy testing. Model input variables were frequently missing immediate or delayed onset (71%), signs or symptoms (13%), and treatment (31%). The gradient-boosted model was the strongest model with an AUC of 0.67 (95% confidence interval [CI] 0.57-0.77), which improved to 0.87 (95% CI 0.73-1) when only cases with complete data were used. Top SHAP drivers for positive testing were reactions within the last year and reactions requiring medical attention; female sex and reaction of hives/urticaria were also positive drivers.

CONCLUSIONS:

An ML prediction model for positive penicillin allergy skin testing using US-based retrospective data did not achieve performance strong enough for acceptance and adoption. The optimal ML prediction model for positive penicillin allergy testing was driven by time since reaction, seek medical attention, female sex, and hives/urticaria.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Penicilinas / Hipersensibilidad a las Drogas / Aprendizaje Automático Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Penicilinas / Hipersensibilidad a las Drogas / Aprendizaje Automático Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos